The decision marks the largest acquisition ever for Johnson & Johnson, at $21.3 billion, according to a report from The Washington Post. Approximately 75 percent of eligible voters were present for the session.
The acquisition is still waiting on clearance from regulatory bodies in the United States and Europe. Pending approval, the deal could be closed by June 2012.
Related Articles on Orthopedic Device Companies:
Smith & Nephew Cuts 80 Jobs in Memphis for Restructuring
K2M Names Don O’Hearn Senior Vice President of Sales in the Americas
VertiFlex Completes Superion Interspinous Trial Enrollment
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.